Cargando…
The global mRNA vaccine patent landscape
In light of their quick development and low risk, mRNA vaccines are gradually replacing traditional vaccines. In order to characterize the patent landscape of mRNA vaccines, this study collated mRNA vaccine–related applications that have been registered since 1962. Accordingly, the 1852 patent famil...
Autores principales: | Li, Mengyao, Ren, Jianxiong, Si, Xingyong, Sun, Zhaocai, Wang, Pingping, Zhang, Xiaoming, Liu, Kunmeng, Wei, Benzheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746484/ https://www.ncbi.nlm.nih.gov/pubmed/35797353 http://dx.doi.org/10.1080/21645515.2022.2095837 |
Ejemplares similares
-
What, Where, When and How of COVID-19 Patents Landscape: A Bibliometrics Review
por: Liu, Kunmeng, et al.
Publicado: (2022) -
Global landscape of patents related to human coronaviruses
por: Liu, Kunmeng, et al.
Publicado: (2021) -
Broken hearts in mice repaired using mRNA coronavirus vaccine technology
por: Le Page, Michael
Publicado: (2022) -
Global research on artemisinin and its derivatives: Perspectives from patents
por: Liu, Kunmeng, et al.
Publicado: (2020) -
mRNA technology may treat stubborn diseases
por: Le Page, Michael
Publicado: (2022)